The relation between renal function and serum sclerostin in adult patients with CKD. - Wikidata - wikimedia - TriplyDB

The relation between renal function and serum sclerostin in adult patients with CKD.

The relation between renal function and serum sclerostin in adult patients with CKD.

http://www.wikidata.org/entity/Q36810475

about

Sclerostin Antibody Therapy for the Treatment of Osteoporosis: Clinical Prospects and Challenges Novel biological markers of bone: from bone metabolism to bone physiology Molecular Abnormalities Underlying Bone Fragility in Chronic Kidney Disease.Teriparatide treatment in a heart transplant patient with a chronic kidney disease and a low-turnover bone disease: a case report Interactions of sclerostin with FGF23, soluble klotho and vitamin D in renal transplantation Role of TGF-β in a mouse model of high turnover renal osteodystrophy.Chronic kidney disease and osteoporosis: evaluation and management.Bone mineral density and serum biochemical predictors of bone loss in patients with CKD on dialysis.The effect of renal dysfunction on circulating sclerostin level in patients with type 2 diabetes.Ankle-brachial index and bone turnover in patients on dialysis Markers of bone metabolism are affected by renal function and growth hormone therapy in children with chronic kidney disease.Anti-sclerostin antibody treatment in a rat model of progressive renal osteodystrophy.Chronic kidney disease and the skeleton.Only minor differences in renal osteodystrophy features between wild-type and sclerostin knockout mice with chronic kidney disease.Treatment with cinacalcet increases plasma sclerostin concentration in hemodialysis patients with secondary hyperparathyroidism.Circulating levels of sclerostin but not DKK1 associate with laboratory parameters of CKD-MBD.Serum Sclerostin as an Independent Marker of Peripheral Arterial Stiffness in Renal Transplantation Recipients: A Cross-Sectional Study.Recent advances in the noninvasive diagnosis of renal osteodystrophy.Serum sclerostin levels in renal cell carcinoma patients with bone metastases Sclerostin is positively associated with bone mineral density in men and women and negatively associated with carotid calcified atherosclerotic plaque in men from the African American-Diabetes Heart Study.Clinical utility of serum sclerostin measurements.Sclerostin and CKD-MBD.Osteoprotegerin and sclerostin in chronic kidney disease prior to dialysis: potential partners in vascular calcifications.Sclerostin, Osteocytes, and Chronic Kidney Disease - Mineral Bone Disorder.The Kidney-Vascular-Bone Axis in the Chronic Kidney Disease-Mineral Bone Disorder.Sclerostin, TNF-alpha and Interleukin-18 Correlate and are Together with Klotho Related to Other Growth Factors and Cytokines in Haemodialysis Patients.Novel bone metabolism-associated hormones: the importance of the pre-analytical phase for understanding their physiological roles.Hormonal and systemic regulation of sclerostin.The chronic kidney disease - Mineral bone disorder (CKD-MBD): Advances in pathophysiology.Biomarkers Predicting Bone Turnover in the Setting of CKD.Higher serum sclerostin levels and insufficiency of vitamin D are strongly associated with vertebral fractures in hemodialysis patients: a case control study.Sclerostin as a new key factor in vascular calcification in chronic kidney disease stages 3 and 4.Serum sclerostin values are associated with abdominal aortic calcification and predict cardiovascular events in patients with chronic kidney disease stages 3-5D.The role of biochemical of bone turnover markers in osteoporosis and metabolic bone disease: a consensus paper of the Belgian Bone Club.Associations between the levels of sclerostin, phosphate, and fibroblast growth factor-23 and treatment with vitamin D in hemodialysis patients with low intact PTH level.Sclerostin and chronic kidney disease: the assay impacts what we (thought to) know.Serum sclerostin: relation with mortality and impact of hemodiafiltration.Role of the Wnt/β-Catenin Pathway in Renal Osteodystrophy.Fragility Fractures in Chronic Kidney Disease: Assessment and Pharmacologic Management

P2860

Q26744599-7130C88C-E4FA-48E4-A267-4CF4EED9B22B Q28067712-DCBB2923-7DED-489F-8A19-06BA1E934333 Q30234751-55655FAA-2D7C-401D-9CBC-92517467D0F9 Q33607092-A817801E-6B63-4520-819A-44AFFFA26712 Q33739417-B7B82B44-D815-4942-A205-C2A4B40028E9 Q33827652-52B9834B-A725-4D88-B5A7-1DD6DBA24CBB Q33833414-D2EFC8DB-438E-47E5-A783-F37146287FC2 Q33835723-F0989EB5-ACCF-4D1E-B203-6C158D09DCF4 Q33905129-E45F2702-260C-4A04-A291-7920FD254AF0 Q35027284-6119BB57-508B-4082-8085-0395E4B675AF Q35058295-48CD26EE-EB27-4C64-B092-CBC574172993 Q35096719-2CF61166-E7CF-407C-AF14-FFFB4A4E1264 Q35755179-C6617120-5305-482C-9581-D3EB12298222 Q36104700-5F87D4BB-5238-432F-B57A-EDCBA4B55A22 Q36193227-30B850AF-747E-4678-95BC-1A70F74997D2 Q36368980-90A01EB0-A40A-4796-ACCF-1EC3580BD717 Q36822357-74DEDF3C-0C3B-4C2F-A7C9-FA6C97107BB4 Q37248630-368176F0-95F1-4D45-95B4-F29D90339D8F Q37282121-E6138BDE-4E04-4CEC-BED4-C7AD33775E99 Q37428965-C4EC051B-1B15-47DA-81DC-97EF61AEC6B9 Q37605570-4F4B9EE8-7BDA-4EF0-8C33-6B8692C1153F Q38359423-0A533BD2-8D20-4B91-8CA3-5B56480CD4C8 Q38411782-7CE6FB91-786E-4FA4-9E70-D538F1AB3D56 Q38569480-1D24FB6B-6941-4A83-B30B-64EFEFA928D3 Q38584122-8E39D4B0-5B52-4E4A-8B47-0C9A0A260573 Q38955348-DAA703F6-1D2D-4443-91FE-024C574EC5AB Q38970563-05D6D7CB-BFEE-4A29-9F92-8C788E1A22A6 Q39037907-1EA08CCB-2AD6-44CF-968F-E94177C1D095 Q39101623-64431FE4-001F-48AD-A178-89AEF28389EA Q39254025-59D8D1C5-E2BB-4250-AE32-CD4E00D72961 Q39342144-8B3D75C2-200E-4152-99C1-4C047DA7C943 Q39552618-9F4346A6-2D7D-46E9-B9F8-759F64698AA9 Q40760789-8577A649-00BC-45C0-BDD1-66B83F9D13C0 Q40828040-CD17FA64-6587-4849-8820-889AC17F25B3 Q44250442-22381074-E229-40CD-A367-C5D4A7AD36F6 Q47630210-A8237751-BF30-48E3-853C-18AF7FCFF22D Q53073924-2776E088-8967-494C-9177-AE70F6402881 Q55026099-92E846E1-FDEE-4550-A259-83D85F52D230 Q59051207-3F93C585-3A1F-4913-B274-3D6CC9646B36

P2860

The relation between renal function and serum sclerostin in adult patients with CKD.

http://www.wikidata.org/entity/Q36810475

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

The relation between renal function and serum sclerostin in adult patients with CKD.

@ast

The relation between renal function and serum sclerostin in adult patients with CKD.

@en

type

label

The relation between renal function and serum sclerostin in adult patients with CKD.

@ast

The relation between renal function and serum sclerostin in adult patients with CKD.

@en

prefLabel

The relation between renal function and serum sclerostin in adult patients with CKD.

@ast

The relation between renal function and serum sclerostin in adult patients with CKD.

@en

P1433

Q36810475-07DF7AF7-EB13-419C-BFED-3FB0B7BA1E29

P1476

Q36810475-52B63C80-7C4D-4F57-AF76-6AE71F16CA31

P2093

Q36810475-1699593B-9B50-459B-ACC7-2C150AD337D3

Q36810475-6DB3C2E3-3FFA-41C9-A0A1-9A3F642B17E7

Q36810475-B4FE5B03-EDAD-4C7B-8761-7C39879A45E1

Q36810475-F585D1A7-7BFF-4899-AE99-125EFCC52B32

P2860

Q36810475-1FCA6A9D-6C4C-4587-AAA6-CEA16ADDC2E0

Q36810475-4D16A9E9-A803-4BD1-81D4-782546B9C80D

Q36810475-5477232F-B309-4FFF-A093-93997CD7948A

Q36810475-6F09C48C-853B-4D27-B399-E644A99DD2D7

Q36810475-6F848F01-CF3C-4725-B649-22A79C758FBB

Q36810475-7BE94CED-4DAF-4C9B-9DF2-E3958194BF15

Q36810475-7C704526-9736-48D0-82AE-F002FF170951

Q36810475-7DFFA165-BC27-48E5-9944-71187F434492

Q36810475-81C17EF7-908D-4EF2-A25E-761B5BC95887

Q36810475-8AFB65EC-B071-4D49-9321-FBE563962D16

P304

Q36810475-AC464388-ED8E-403E-8662-C4D6BA5F189C

P31

Q36810475-A9C8F777-E981-4C00-83AA-13BD5C5BC8A8

P356

Q36810475-FF2F6DA4-9E28-4F1D-8EDB-E8AB09F49875

P433

Q36810475-E1A673A2-4D23-406B-AF0B-5B92AFD3DE4A

P478

Q36810475-8B4C2B8C-0D67-442D-AC7A-F79B19903BAF

P50

Q36810475-CD6D4397-624E-4732-9F89-5225F60C110B

P577

Q36810475-164583CF-0B15-40CD-94C7-9B71D4A214E4

P698

Q36810475-99A2EABC-F74B-4ECA-9DA7-6C80E773107C

P932

Q36810475-0EC4E325-67D6-439D-A42D-D319959624A6

P356

P1433

Clinical Journal of the American Society of Nephrology

P1476

The relation between renal function and serum sclerostin in adult patients with CKD

@en

P2093

Aoumeur Hadj-Aissa

http://www.w3.org/2001/XMLSchema#string

Laurence Dubourg

http://www.w3.org/2001/XMLSchema#string

Marie-Christine Carlier

http://www.w3.org/2001/XMLSchema#string

Solenne Pelletier

http://www.w3.org/2001/XMLSchema#string

P2860

Adiponectin in chronic kidney disease is related more to metabolic disturbances than to decline in renal function

Sclerostin antibody treatment increases bone formation, bone mass, and bone strength in a rat model of postmenopausal osteoporosis

Serum sclerostin levels negatively correlate with parathyroid hormone levels and free estrogen index in postmenopausal women.

Sclerostin: current knowledge and future perspectives.

Sclerostin and its association with physical activity, age, gender, body composition, and bone mineral content in healthy adults.

Effects of parathyroid hormone treatment on circulating sclerostin levels in postmenopausal women

Sclerostin and Dickkopf-1 in renal osteodystrophy.

Regulation of circulating sclerostin levels by sex steroids in women and in men.

Determination of serum and plasma sclerostin concentrations by enzyme-linked immunoassays.

Relation of age, gender, and bone mass to circulating sclerostin levels in women and men.

P304

819-823

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2215/CJN.07670712

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P50

P577

2013-02-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23430206

http://www.w3.org/2001/XMLSchema#string

P932

3641616

http://www.w3.org/2001/XMLSchema#string